Startup profile · funding coverage
Lassie funding, valuation and investors
AI agents that automate small-business back offices—starting with dental and medical practices.
Keep track of Lassie
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series A
~$35–47M (reported range; exact not confirmed in single source) · 2025
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
Not publicly disclosed
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series a · San Francisco, California
Investors in latest funding
Lead: Andreessen Horowitz
Overview
Lassie (lassie.ai) builds AI agents that run back-office operations for small businesses, with initial focus on dental and medical practices—automating scheduling, insurance verification, billing follow-ups, and patient communications. The company raised a Series A in 2025 reported at roughly $35–47 million led by Andreessen Horowitz per a16z portfolio announcements. Lassie is explicitly not the Swedish pet insurance unicorn of the same name. The product targets owner-operated clinics where admin overhead consumes clinician time and hiring is difficult.
Why Lassie is interesting
Distinct from Swedish pet insurer Lassie, this a16z portfolio company deploys autonomous agents for scheduling, billing, and admin at SMB clinics—a vertical agent play before horizontal copilots commoditized.
Product & use cases
Lassie deploys AI agents integrated with practice management systems to handle repetitive admin—phone calls, forms, claims, and scheduling—with human escalation when needed.
- Dental practice insurance verification and billing follow-up
- Medical clinic appointment scheduling and patient reminders
- SMB back-office automation beyond healthcare verticals over time
Key facts
- Series A (2025): led by a16z per portfolio announcement
- AI agents for dental/medical practice admin
- Distinct from Swedish pet insurer Lassie
- Targets SMB clinics with heavy admin burden
Funding history (newest first)
Series A
2025 ~$35–47M (reported range; exact not confirmed in single source)Investors in our directory
Funds linked from Lassie's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Vertical depth in dental/medical workflows—not generic chatbots—where EHR and PMS integrations create switching costs.
Vertical AI agents for clinics compete with RCM incumbents and practice-management vendors adding copilots. Lassie must prove reliability on regulated workflows where errors trigger billing denials or compliance issues.
-
Notable / Akasa adjacent
Healthcare RCM automation; overlapping clinic admin buyers.
-
Traditional BPO / virtual assistants alternative
Human offshore admin vs AI agents.
-
Lassie (pet insurance, Sweden) adjacent
Unrelated company—same name, different category.
Notable stories
- Name collision with European pet insurance unicorn requires disambiguation in every profile.
- a16z Series A reflects 2025 vertical AI agent thesis—SMB ops before enterprise copilots.
- Initial wedge in dental practices where scheduling and insurance verification are daily pain points.
Industries
Related funding articles
Venture Capital Tracker pieces that cover Lassie's financing or category context.
FAQs about Lassie
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.